Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection

NCT02609659 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Virus (HCV)

Interventions

DRUG: ombitasvir/paritaprevir/ritonavir and dasabuvir
DRUG: ribavirin

Sponsor

AbbVie